12 August 2022 (Friday) - Transfusion News Update

Tranexamic acid, HDFN, racial thresholds for transfusion… I learned a few things here. And that’s what CPD is all about…

Safety and Effectiveness of Tranexamic Acid in Cardiac Surgery Patients

Transfusion News Image 1
August 10, 2022
Tranexamic acid is an antifibrinolytic agent that is commonly used to control bleeding in patients undergoing cardiac surgery. Limited randomized controlled trial data, however, are available to determine the optimal dose. High doses of tranexamic acid have been associated with seizures and thrombotic events. [Read More]
Join us to hear about existing strategies to either prevent, or diagnose and treat HDFN
Transfusion News Image 1
In this new Transfusion Science Webinar, Carla Dinardo, MD, PhD, explains why the Hemolytic Disease of the Fetus and Newborn remains a challenge despite the many advances made to either prevent, or diagnose and treat HDFN and its complications. [Register Now]
Racial Differences in Red Blood Cell Transfusions
Transfusion News Image 1
August 3, 2022
Transfusion guidelines recommend transfusing red blood cells (RBCs) when hemoglobin (Hb) levels drop below 7 or 8 g/dL, but variation in transfusion practices remain. In order to better understand racial differences in transfusions in hospitalized general medicine patients with anemia [Read More]
Hypocalcemia Associated with Increased Transfusion Requirements in Pediatric Trauma Patients
Transfusion News Image 1
July 27, 2022
Hypocalcemia (Ca++ <1.1 mmol/L) has recently been identified as a fourth component of the “lethal triad” for mortality of adult trauma patients in addition to coagulopathy, acidosis, and hypothermia. Severe hypocalcemia (Ca++ <1.0 mmol/L) is common, occurring in about a quarter to half of all severely injured adult patients. [Read More]


No comments:

Post a Comment